Boylan James P 4
4 · Compass Therapeutics, Inc. · Filed Mar 11, 2024
Insider Transaction Report
Form 4
Boylan James P
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-03-08+40,000→ 40,000 totalExercise: $1.96Exp: 2034-03-07→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The options vest over 48 substantially equal monthly installments starting April 8, 2024.
- [F2]The Reporting Person is a member of Enavate Sciences, LP ("Enavate"). Pursuant to an agreement with Enavate, the Reporting Person has agreed to receive and hold for the benefit of Enavate any securities issued under any stock options or other awards granted to him for his services as a director on the Issuer's board of directors. As such, the Reporting Person disclaims beneficial ownership of, and all right, title and interest in, the reported securities.